Compare AGD & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AGD | SOPH |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | United Kingdom | Switzerland |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.1M | 330.4M |
| IPO Year | N/A | 2021 |
| Metric | AGD | SOPH |
|---|---|---|
| Price | $11.59 | $4.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 61.2K | 56.4K |
| Earning Date | 01-01-0001 | 11-04-2025 |
| Dividend Yield | ★ 8.13% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $73,297,000.00 |
| Revenue This Year | N/A | $18.32 |
| Revenue Next Year | N/A | $15.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 13.66 |
| 52 Week Low | $8.20 | $2.58 |
| 52 Week High | $9.78 | $5.30 |
| Indicator | AGD | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 46.70 | 50.54 |
| Support Level | $11.71 | $4.56 |
| Resistance Level | $12.30 | $4.82 |
| Average True Range (ATR) | 0.21 | 0.18 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 26.80 | 42.41 |
Aberdeen Global Dynamic Dividend Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current dividend income, more than 50% of which qualifies for the reduced federal income tax rate, as created by the Jobs and Growth Tax Relief Reconciliation Act of 2003. The fund also focuses on the long-term growth of capital as a secondary investment objective. The fund's portfolio holdings are in information technology, financials, health care, and consumer discretionary sectors among others.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.